Illumina Patent Claims Invalidated In DNA Sequencing Row
A California federal judge on Tuesday invalidated nine of Illumina's claims to a patent covering a DNA sequencing method that Complete Genomics Inc. is accused of flouting....To view the full article, register now.
Already a subscriber? Click here to view full article